American Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

American Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-90,000	Closed	-$882K	–	138
2019 Q4	$882K	Hold	90,000	–	–	0.08%	90
2019 Q3	$619K	Hold	90,000	–	–	0.05%	106
2019 Q2	$831K	Hold	90,000	–	–	0.07%	103
2019 Q1	$1.41M	Hold	90,000	–	–	0.12%	93
2018 Q4	$1.39M	Hold	90,000	–	–	0.13%	97
2018 Q3	$1.94M	Hold	90,000	–	–	0.19%	83
2018 Q2	$2.19M	Hold	90,000	–	–	0.21%	77
2018 Q1	$1.54M	Hold	90,000	–	–	0.15%	90
2017 Q4	$1.71M	Sell	90,000 -90,000	-50%	-$1.35M	0.18%	82
2017 Q3	$3.17M	Hold	180,000	–	–	0.33%	67
2017 Q2	$5.98M	Hold	180,000	–	–	0.57%	55
2017 Q1	$5.78M	Hold	180,000	–	–	0.53%	60
2016 Q4	$6.53M	Buy	+180,000	New	+$7.19M	0.63%	57

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

American Financial Group's TEVA Position: Q1 2020 in Review

American Financial Group sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 90,000 shares — an estimated $882K sold.

American Financial Group first reported a position in TEVA in Q4 2016 and held it in 13 quarters. The position peaked at $6.53M in Q4 2016. 460 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

American Financial Group reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
American Financial Group sold 90,000 Teva Pharmaceuticals shares in Q1 2020, an estimated $882K.
American Financial Group first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 13 quarters.
American Financial Group's Teva Pharmaceuticals position peaked at $6.53M in Q4 2016.
460 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on American Financial Group's 13F filing for Q1 2020, filed 12 May 2020.